Caas Capital Management LP Rapt Therapeutics, Inc. Transaction History

Caas Capital Management LP

  • $836 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$29.86 - $39.47 $3.84 Million - $5.07 Million
-128,480 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$17.99 - $40.02 $2.31 Million - $5.14 Million
128,480 New
128,480 $4.08 Million
Q4 2020

Feb 12, 2021
SELL
$15.89 - $40.87 $389,130 - $1 Million
-24,489 Closed
0 $0
Q3 2020

Nov 09, 2020
BUY
$21.6 - $37.5 $528,962 - $918,337
24,489 New
24,489 $789,000

Others Institutions Holding RAPT

# of Institutions
104
Shares Held
27.1M
Call Options Held
26.7K
Put Options Held
2.4K
View Full List

About RAPT Therapeutics, Inc.

RAPT Quotes by TradingView
  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $48M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email